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Introduction
Gliomas are represented by a heterogeneous g roup of 
tumors and made up essentially by two main populations of 
glial cells: oligodendrocytes and astrocytes. Cancer stem cells 
can be isolated from particular tumors and are thought to be 
the cause of chemo- and radiotherapy resistance and tumor 
relapse. The main data concerning tumoral in vivo energetic 
metabolism derives from spectroscopic imagistic data SPET 
(positron emission tomography) utilizing 2-FDG (fluoro-de-
oxy-D-glucose) and methyonine as a tracer [2, 3, 4]. Based on 
these results, it was widely recognized that some cancer cell 
types show enhanced glycolysis levels [1, 10]. High glucose 
turnover and lactate production might represent an adaptive 
mechanism in response to increasing hypoxia accompanying 
tumoral progression. Moreover, resulted peritumoral acidosis 
is regarded as one of tumoral aggressive factors for surroun-
ding normal cells. A reduced spatial and temporal resolution 
of metabolic studies via PET scan imagery is incriminated by 
the impossibility to evaluate specific metabolic profiles for 
each cell type involved in tumoral formation.
In an attempt to establish the correlation between glioma 
CSCs energetic metabolism and tumoral aggressiveness, 
four types of glioma stem cells were isolated from tumors 
originating from the brain stem, thalamus, and hemispheres. 
Energetic metabolism of spheroids of CSCs evaluated by 
NADH levels depending on glucose levels in cultural media 
and treated with antimetabolite 2DG in some conditions was 
compared with neural stem cells originating from a neonatal 
mouse.
Material and Methods
Four cancer stem cell lines were isolated using classical 
methods. 2 adult glioma cells originated from the thalamus 
and frontal lobe for which an anatomopathologic study reve-
aled an anaplastic glioma grade III of malignancy according 
to the WHO classification, and 2 child anaplastic gliomas 
from brain stems with similar degree of malignancy. Each 
type of glioma stem cell was cultured and maintained in an 
atmosphere with similar CO2 and O2 contents. Different 
types of cell culture media were used for adult and child stem 
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Abstract
Tumor cell energy metabolism is often invoked as marker of aggressiveness and resistance in the study of cancer. Warburg was the first researcher 
to propose the high consumption of glucose and reduction of tumor cell oxidative metabolism as prominent feature of cancer cells.  In clinical practice, 
this feature is used in PET imaging (positron emission tomography) to visualize the 2-FDG antimetabolite enhancing lesions.  In reality, not all tumors 
are characterized by high levels of glycolysis. To highlight certain features affected by glucose and energy, four types of cancer stem cells (CSCs) were 
isolated from the third degree of malignancy gliomas (anaplastic glioma, WHO, World Health Organization). The NADH cells’ levels of CSCs in sphere 
cultures where evaluated and compared to a proliferation index. Surprisingly, the cells with the highest proliferation index showed a lowest ratio of NADH/
proliferation. Thus, the energy status of cancer stem cells lines derived from gliomas is inversely correlated to proliferation in vitro. Glucose dependency 
varied considerably among the four types of glioma stem cells. In one case, NADH levels were maintained in the absence of glucose by substitution with 
glutamine. DCA (dichloroacetat) is an energy modulator acting as a mitochondrial function stimulator. In our experiments, DCA could stimulate NADH 
production, showing the possibility of mitochondrial function recovery in glioma cancer stem cells.
Key words: cancer, glioma stem cells, tumor cell energy metabolism.
Энергетический обмен стволовых клеток глиомы
В исследовании агрессивности и сопротивления рака часто используются особенности энергетического метаболизма опухолевых клеток. 
Варбург был первым, кто поставил акцент на высокий уровень потребления глюкозы и снижения окислительной функции опухолевых клеток. 
В клинической практике эта функция используется в ПЭТ (позитронно-эмиссионной томографии), сканирование с помощью метаболит 
2-FDG. На самом деле, не все опухоли можно охарактеризовать высоким уровнем гликолиза.  Для характеристики зависимости от глюкозы 
и выделения некоторых энергетических особенностей были выделены из глиомы четыре типа стволовых клеток, с сопоставимой степени 
злокачественности (3 anaplastic – 3 анапластической, Всемирная Организация Здравоохранения). Удивительно, что стволовые клетки с 
высоким индексом пролиферации показали самый низкий уровень NADH (энергетический эквивалент снижения). Энергетический статус 
нормальных нервных стволовых клеток, вызванный NADH, был самым высоким.  Зависимость от глюкозы значительно различалась между 
четырьмя типами стволовых клеток глиомы, а в одном случае, уровень NADH был сохранен в отсутствие глюкозы при замещении глутамина. 
При лечении с DCA (dichloroacetat) производства NADH можно стимулировать, показывая вожможность частичного восстановления 
митохондриальной функции опухоли.
Ключевые слова: рак, глиома, энергетический обмен стволовых клеток.
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cells gliomas to assure best proliferation rates. TP54 and TP84 
stem cell lineages from the adult glioma were cultured in a 
“house” prepared D3 media: DMEM-F12 1X liquid 10 ml, 
Glucose 30% 200 μl. (50.8 mM), Glutamine 200 mM 100 μl 
(2 mM), Penicillin Streptomycin 100 μl g/ml 10 μl (0.1 mkg), 
with a neural stem cell supplement 50 X 200 μl, Heparin 20 
mg/ml 0.5 μl (20 mg/ml), EGF (epidermal growth factor) 
1 μl (20 ng/ml), bFGF 1 μl (basic fibroblast growth factor) 
(10 ng/ml). TG10 and OB1 stem cell lineage derived respec-
tively from child brain stem glioma was cultured in a NS34 
media: N2100 x and B27 50 X, G5100 x 1 ml (Stem Cell). The 
SCN24 neural stem cells from the mouse were cultured in a 
standardized media from Stem Cell.
In order to test each stem cell line dependence on main 
nutrients, each cell lineage was resuspended in the same D3 
culture media with known concentrations of Glucose and 
Glutamine for 24 hr. prior to glucose and glutamine depriva-
tion. NADH or NADPH “reducing equivalents” as markers 
of energetic metabolism in viable cells has been quantified by 
WST test (Roche). The same number per well were seeded 
(20.000) and the cell viability essay was performed by Blue-
Trepan exclusion method.
In the second essay, we treated our glioma stem lines 
and neural stem cell lines with several modulating energy 
metabolism agents: DCA (dichloracetate), which accelerates 
the Krebs cycle by inhibiting the activity of PDK (pyruvate 
dehydrogenase kinase); 2 DG (2 deoxy-D-glucose) an analog 
of glucose that blocks the first step of glycolysis; Antimycine 
A - a mitochondrial inhibitor which is involved in the ener-
gy-coupling site of the respiratory system by blocking the 
electrons flow from cytochrome b to cytochrome c1.
Results
Under the same cultured condition (white column) the 
NADH activity was greater for stem cell lines derived from 
child brain stem glioma. The dark column represents NADH 
activity when cultured in the original media. Interestingly, 
the proliferative index (data not shown) was greater for the 
stem cell line derived from the adult brain glioma, thus the 
cell proliferation rates inversely correlated with metabolic 
NADH activity (fig. 1).
Great differences were revealed in the metabolic activity 
of stem cell lines derived from morphologically similar grade 
III (WHO) gliomas. The TP54 cell line maintained the same 
activity of NADH with Glutamine 2 mMol in the media as 
with Glucose 10 mMol, demonstrating the great adaptability 
of TP54 compared withTP84 (fig. 2).
Fig. 2. Differences in stem cell dependency on Glucose versus 
Glutamine for NADH production.
The CSN24 mouse neural stem cell line treated with 2DG 
(2-deoxy glucose) shows little or no blockage of NADH acti-
vity, indicating both a low cell glycolytic activity and a relative 
resistance to 2DG antimetabolite (fig. 3).
Fig. 3. Metabolic activity modulation in the neural 
stem cell line.
Fig. 1. Metabolic activity (NADH) of 4 different stem 
cell lines in cultured media.
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The TG10 stem cell line derived glioma from child brain 
stems treated with 2DG shows a net reduction of metabolic 
activity compared to CSN24. In contrast, DCA stimulated 
Krebs cycle activity, confirming an inhibited status of mito-
chondria in cancer (fig. 4).
Fig. 4. Stem cell lines derived from glioma TG10; in conditions 
with two antimetabolite 2DG (2-deoxyglucose) and AMA-
Antimycine A, and stimulating drug DCA (dichloracetate).
Discussion 
“Cancer cells originate from normal body cells in two phases. 
The first phase is the irreversible injuring of respiration. The 
irreversible injuring of respiration is followed, as the second 
phase of cancer formation”. (On the origin of cancer cells, 
Otto Warburg, 1956).
It has previously been emphasized that, beyond its impact 
in terms of diagnosis, growth patterns analysis, and aberrant 
energetic metabolism evaluation provide valuable insights 
into the clinical manifestation and imaging of tumors. Seve-
ral studies demonstrate the role of PET scan imaging based 
on high glycolysis cells on tumoral diagnosis and prognostic 
evaluation [2, 7]. Thus, the 2-FDG PET scan (fluoro-deoxy-
glucose positron emission tomography) is largely utilized 
in clinics for evaluation of local and distant lymph node 
metastasis. A metabolic study of FDG PETs shows a better 
specificity and sensitivity compared to the conventional CT 
(computer tomography) and MRI (magnetic resonance ima-
ging) techniques with 79-85% and 90-99% respectively [2, 9]. 
Finally, the great resolution of the FDG PET scan makes it a 
first choice exam in some cancers type: head and neck, breast, 
lung, colorectal, melanoma and lymphoma tumors [3, 4, 5]. 
Energetic metabolism and some key enzymes particularly 
implicated in glycolysis and oxidative phosphorilation have 
been studied as potential markers of tumoral aggressiveness. 
For example, based on immunohystochemical evaluation 
of GAPDH (glyceryl aldehyde phosphate dehydrogenase), 
beta-1 ATPase subunit (adenosine triphosphate beta-1) and 
HSP (heat shock protein from mitochondrial membrane), an 
energetic index has been calculated and proposed to express 
tumoral metabolic status and prediction marker of tumoral 
aggressiveness (Guezva 2004).
A strong relationship has been found between high glyco-
lytic phenotype and tumoral aggressiveness. Indeed, several 
facts indicate that, either FDG captation or Lactate levels 
determined by spectro MRI exams, constitute negative pre-
diction factors in tumoral behavior [8, 9, 10]. It was stressed 
that Warburg effect might represent an adaptive mechanism 
for tumoral cells to overcome increased hypoxia rates and 
insufficient vascular supply. Consequently, targeting tumoral 
metabolism and, more specifically, glycolysis is considered 
a promising tool in anticancer therapy. Prior to deciding 
which anti-metabolite therapy would be the most producti-
ve, a thorough appreciation of energetic metabolism should 
be undertaken in order to confirm or infirm characteristics 
like: enhanced glycolysis, glutaminolysis [4]. However, there 
is a growing awareness that glycolytic phenotypes vary sig-
nificantly, as many tumors cannot be visualized by FDG PET 
scans. Also, it has been suggested that nutrients other than 
glucose might be utilized as main energetic suppliers: gluta-
mine and even lactate [5, 6, 7]. Few studies have addressed 
these issues or tried to explain these metabolic differences in 
stem cells derived from gliomas.
Stem cells that derive from tumors being denominated as 
cancer stem cells are seldomly regarded as therapy resistant 
factors and reflect the most aggressive part of the tumor. In 
our study, several lines of stem cells derived from different gli-
omas but appreciated to have the same WHO III malignancy 
degree have been tested for their susceptibility to glucose and 
glutamine withdrawal. Comparing different cell lines obtained 
from adult and child glioma and also normal neural stem 
cell lines, showed that the NADH production was constantly 
inferior for cancer stem cells with the highest proliferative 
index compared to those with the lowest ones.
Due to these results, the assumption that cancer cells are 
driven by high energy demanding processes and/or glycolysis 
upregulation results in more ATP (adenosine triphosphate) 
production than in normal cells has not been validated. 
Several studies capitalized on NMR spectroscopy (nuclear 
magnetic resonance spectroscopy) using 13C isotopomer 
for glucose labeling, drawing the conclusion that enhanced 
energetic and anabolic metabolism is driven by glycolysis [3]. 
Because glycolysis produces ATP less efficiently than aerobic 
respiration, tumor cells must compensate by having a much 
higher rate of glucose uptake than normal cells. In some 
malignant rapidly-growing tumors, glycolysis rates are up to 
200 times higher than normal cells. AMPK (AMP-activated 
protein kinase) has emerged as a master regulator of cellular 
energy metabolism with dozens of downstream targets. The 
p53 modulator’s main role is in protecting cells from DNA 
(Deoxyribonucleic acid) errors introduced into cell growth 
and division by diverse stress signals and acts by negatively 
regulating the IGF-1/mTOR pathways (insulin-like growth 
factor/mammalian target of rapamycin). IGF-1/mTOR 
hyper-activation is rarely encountered in tumoral cells, while 
p53 anti-oncogene is lost in almost 70% of tumors. The well 
known targets of p53 are the TSC2 (tuberous sclerosis), PTEN 
(Phosphatase and tensin homolog), and IGF genes- but also 
the A subunit of AMPK-AMPK β1 with direct implication in 
tumoral energy metabolism [5]. All these facts indicate that 
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energetic metabolism is rather inefficient in some types of 
tumoral cells, as for the same amount of glucose, less of NADH 
is produced. In our study, we have confirmed this assumption 
and found by direct NADH measurement that proliferative 
cellular indexes correlate indirectly with NADH production. 
The aberrant metabolism sustained by genetic abnormalities 
confers the obvious advantage by deviating energy resources 
to synthetic proliferative processes [6, 7, 8].
Further, we have tried to assess the influence of several 
anti-metabolites on NADH produced by either cancer or 
normal neural stem cells. We found that DCA, which acts 
as inhibitor of Pyruvate Dehydrogenase Kinase, accelerating 
oxidative phosphorilation, can enhance energetic metabolism 
in glioma stem cells, but has no effect on neural stem cells. This 
fact proves that despite genetic modification in tumoral cells, 
some functions, and more specifically oxidative phosphorila-
tion functions, can be restored. It has been shown earlier that 
p53 loss results in a defect in oxygen consumption, which 
suggests a decreased function of mitochondrial respiration [6, 
8]. Still, on the basis of glioma stem cell metabolism we veri-
fied a previously announced hypothesis of DCA enhancing 
properties on tumoral mitochondria. In the same study, we 
found that glucose was an obligatory fuel for several types of 
glioma, in our case for the stem cells derived from two child 
glioma and one adult glioma. In one case of stem cell line 
derived from adult glioma, the NADH production could be 
maintained solely by glutamine.
As it was expected, glycolysis inhibition by 2-Deoxy-D-
Glucose resulted in marked NADH inhibition in cancer stem 
cells and only moderately for neural stem cells.
Conclusion
An aberrant energetic metabolism in cancer was confir-
med on the basis of glioma stem cells compared to neural stem 
cells. Primarily, for an apparently similar degree of malignancy 
established anatomopathologically, energetic study showed 
significant differences in tumoral dependence on glucose and 
glutamine. Secondly, proliferative index correlated inversely 
with cellular energetic status.
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